Kiehne K, Rozengurt E
Imperial Cancer Research Fund, London, United Kingdom.
J Cell Physiol. 1995 Mar;162(3):367-77. doi: 10.1002/jcp.1041620309.
Preincubation of quiescent Swiss 3T3 cells in fresh synthetic medium caused a reduction of the lag period prior to bradykinin-stimulated DNA synthesis as well as a leftward shift in the dose-response curve (half-maximum effect at 2 nM and 8 nM for preincubated cells and control cells, respectively). These enhancing effects were selective for bradykinin since vasopressin-stimulated DNA synthesis was not affected by preincubation in synthetic medium. Preincubation in synthetic medium also caused a marked enhancement (five- to sixfold increase) of bradykinin-induced Ca2+ mobilization from intracellular stores. This enhancement was time-dependent, peaked after 12 h of preincubation, and was prevented by inhibition of RNA or protein synthesis. Furthermore, preincubation in synthetic medium did not enhance the Ca2+ mobilization by bombesin, vasopressin, or PDGF. Additionally, bradykinin-induced tyrosine phosphorylation was also enhanced by prior incubation in fresh medium. Scatchard analysis of [3H]bradykinin binding revealed a doubling of the number of bradykinin receptors without any significant change of affinity after preincubation, thus providing an explanation for the increased cellular responsiveness to bradykinin. This enhancement of responsiveness to bradykinin was caused by the removal of an inhibitory factor present in conditioned medium which is produced by the cells and accumulates gradually in the medium. Addition of tumor necrosis factor alpha or interferon beta to synthetic medium substituted for conditioned medium in preventing the increase in responsiveness to bradykinin. These findings demonstrate a novel mechanism that regulates cellular sensitivity to bradykinin via an autocrine factor(s).
将静止的瑞士3T3细胞在新鲜合成培养基中预孵育,可缩短缓激肽刺激DNA合成前的延迟期,并使剂量反应曲线向左移动(预孵育细胞和对照细胞的半数最大效应分别在2 nM和8 nM时出现)。这些增强作用对缓激肽具有选择性,因为加压素刺激的DNA合成不受在合成培养基中预孵育的影响。在合成培养基中预孵育还可显著增强(增加五到六倍)缓激肽诱导的细胞内钙库Ca2+动员。这种增强作用具有时间依赖性,在预孵育12小时后达到峰值,并且可通过抑制RNA或蛋白质合成来阻止。此外,在合成培养基中预孵育不会增强蛙皮素、加压素或血小板衍生生长因子诱导的Ca2+动员。另外,在新鲜培养基中预先孵育也可增强缓激肽诱导的酪氨酸磷酸化。对[3H]缓激肽结合进行Scatchard分析表明,预孵育后缓激肽受体数量增加了一倍,而亲和力没有任何显著变化,从而为细胞对缓激肽反应性增加提供了解释。对缓激肽反应性的这种增强是由于去除了条件培养基中存在的一种抑制因子,该抑制因子由细胞产生并在培养基中逐渐积累。在合成培养基中添加肿瘤坏死因子α或干扰素β可替代条件培养基,从而防止对缓激肽反应性的增加。这些发现证明了一种通过自分泌因子调节细胞对缓激肽敏感性的新机制。